Letrozole: An Updated Review of its Use in Postmenopausal Women with Advanced Breast Cancer

By Keating G.M.   Jarvis B.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 351-371

Adis International

Access to resources Recommend Favorite

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

By Skedgel C.   Rayson D.   Dewar R.   Younis T.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 3, 2007-03 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment

By Kvinnsland S.   Anker G.   Dirix L.-Y.   Bonneterre J.   Prove A.-M.   Wilking N.   Lobelle J.-P.   Mariani O.   di Salle E.   Polli A.   Massimini G.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 976-982

Elsevier

Access to resources Recommend Favorite

Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5 years' Adjuvant Treatment for Early Breast Cancer

By Cella David   Fallowfield Lesley   Barker Peter   Cuzick Jack   Locker Gershon   Howell Anthony  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 273-284

Springer Publishing Company

Access to resources Recommend Favorite

Cost-Effectiveness of Letrozole in the Extended Adjuvant Treatment of Women with Early Breast Cancer

By Ouagari Khalid   Karnon Jon   Delea Thomas   Talbot Willena   Brandman Jane  

Breast Cancer Research and Treatment, Vol. 101, Iss. 1, 2007-01 ,pp. : 37-49

Springer Publishing Company

Access to resources Recommend Favorite